EUVIMEDEUVIMED entdecken
Übersichtsarbeit

LRP4-related signalling pathways and their regulatory role in neurological diseases

Bai-Hui Chen, Ze-Yu Lin, Xiao-Xue Zeng, Yi-Han Jiang, Fei Geng

Brain Research · 2024

DOI: 10.1016/j.brainres.2023.148705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Research, 2024. Verfasst von Bai-Hui Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Shantou University Medical College, Shantou 515041, China. Hauptthemen laut MEDLINE: LDL-Receptor Related Proteins, Agrin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Shantou University Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism of action of low-density lipoprotein receptor related protein 4 (LRP4) is mediated largely via the Agrin-LRP4-MuSK signalling pathway in the nervous system. LRP4 contributes to the development of synapses in the peripheral nervous system (PNS). It interacts with signalling molecules such as the amyloid beta-protein precursor (APP) and the wingless type protein (Wnt). Its mechanisms of action are complex and mediated via interaction between the pre-synaptic motor neuron and post-synaptic muscle cell in the PNS, which enhances the development of the neuromuscular junction (NMJ). LRP4 may function differently in the central nervous system (CNS) than in the PNS, where it regulates ATP and glutamate release via astrocytes. It mayaffect the growth and development of the CNS by controlling the energy metabolism. LRP4 interacts with Agrin to maintain dendrite growth and density in the CNS. The goal of this article is to review the current studies involving relevant LRP4 signaling pathways in the nervous system. The review also discusses the clinical and etiological roles of LRP4 in neurological illnesses, such as myasthenia gravis, Alzheimer's disease and epilepsy. In this review, we provide a theoretical foundation for the pathogenesis and therapeutic application of LRP4 in neurologic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LDL-Receptor Related ProteinsAgrinAmyloid beta-PeptidesReceptor Protein-Tyrosine KinasesNeuromuscular Junction

Stichwörter der Autor:innen

Central nervous systemLRP4Neurological diseasePeripheral nervous systemSignalling pathway

Substanzen

LDL-Receptor Related ProteinsAgrinAmyloid beta-PeptidesReceptor Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Physiology, Shantou University Medical College, Shantou 515041, China.
  • Department of Physiology, Shantou University Medical College, Shantou 515041, China; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical College, Shantou…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Shantou University Medical College

Zitieren

APA

Chen, B. H., Lin, Z. Y., Zeng, X. X., Jiang, Y. H., & Geng, F. (2024). LRP4-related signalling pathways and their regulatory role in neurological diseases. Brain Research. https://doi.org/10.1016/j.brainres.2023.148705

Vancouver

Chen BH, Lin ZY, Zeng XX, Jiang YH, Geng F. LRP4-related signalling pathways and their regulatory role in neurological diseases. Brain Research. 2024. doi:10.1016/j.brainres.2023.148705

BibTeX
@article{Chen2024,
  author = {Chen, Bai-Hui and Lin, Ze-Yu and Zeng, Xiao-Xue and Jiang, Yi-Han and Geng, Fei},
  title = {LRP4-related signalling pathways and their regulatory role in neurological diseases},
  journal = {Brain Research},
  year = {2024},
  doi = {10.1016/j.brainres.2023.148705}
}
Kostenlos starten →